Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amevive Wisdom Acquired Through Real-world Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study

NCT00795353 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00795353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amevive Wisdom Acquired Through Real-world Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Terminated
Start date
July 31, 2008
Completion date
January 31, 2011
Enrollment
64 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic plaque psoriasis